![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex
05 mars 2007 08h00 HE
|
AlphaRx Inc.
MARKHAM, Ontario, March 5, 2007 (PRIME NEWSWIRE) -- AlphaRx (OTCBB:ALRX) announced today the completion of the treatment phase of the double-blind, placebo & vehicle-controlled, randomized and...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx's Nanoparticle Formulation of Antituberculosis Drug Shows Promise in Mice Infected With TB (Mycobacterium Tuberculosis)
20 févr. 2007 08h00 HE
|
AlphaRx Inc.
A leading Chinese TB research institute evaluated the efficacy of the
Company's nanoparticle-encapsulated Streptomycin administered 2 times
a week versus that of daily nonencapsulated drug...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx Provides Positive Update On Indaflex
09 janv. 2007 10h45 HE
|
AlphaRx Inc.
MARKHAM, Ontario, Jan. 9, 2007 (PRIME NEWSWIRE) -- AlphaRx Inc. (OTCBB:ALRX) is pleased to announce that Proprius Pharmaceuticals Inc. has raised up to $17M in a Series A financing. A large portion of...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan in Hong Kong
08 mars 2006 08h00 HE
|
AlphaRx Inc.
MARKHAM, Ontario, March 8, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx Receives Notice of Allowance for U.S. Patent on Its Drug Delivery Platform
25 janv. 2006 08h00 HE
|
AlphaRx Inc.
MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx Updates Binoxan Development, a Potential Non-Irritating, Twice-a-Day Eye Drop for Ocular Inflammation
17 janv. 2006 08h00 HE
|
AlphaRx Inc.
MARKHAM, Ontario, Jan. 17, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan Ultra in Hong Kong
10 janv. 2006 08h00 HE
|
AlphaRx Inc.
MARKHAM, Ontario, Jan. 10, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
![AlphaRx Inc. Logo](/news-release/logo/214920/0/214920.gif?lastModified=12%2F10%2F2016%2021%3A10%3A06&size=2)
AlphaRx Launches Flexogan's First National TV Campaign with World Wrestling Entertainment
01 avr. 2004 08h30 HE
|
AlphaRx Inc.
RICHMOND HILL, Ontario, Canada, April 1, 2004 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX) is launching its first Canadian national TV campaign with World Wrestling Entertainment Canada, Inc. to support...